Rocket Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:RCKT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -74.64 M-121.16 M-178.14 M-194.92 M-209.72 M-190.01 M -170.27 M Cash from investing activities -96.59 M18.85 M-69.33 M-98.07 M131.71 M103.77 M 361.85 M Cash from financing activities 282.99 M37.68 M155.29 M208.4 M185.74 M148 K 82 K Free cash flow -74.64 M-121.16 M-178.14 M-194.92 M-209.72 M-190.45 M -170.39 M

News

Monopar: Licensing Agreement, Rolling NDA Submission Serve As Catalysts For ‘Strong Buy’

Rocket Pharmaceuticals Q2 Earnings Rise Y/Y, Kresladi Launch in Focus

Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

Rocket Pharmaceuticals: Kresladi Validates Platform, Commercial Upside Limited (RCKT)

Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 Transcript

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement

Avago, Lumentum among market cap stock movers on Monday

Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript